Positron emission tomography (PET)/magnetic resonance imaging (MRI)

DIAGNOSTIC_TEST2 trials

Sponsors

Robert Flavell, MD, PhD, University of Wisconsin, Madison

Conditions

Metastatic Castration-resistant Prostate CancerProstate Cancer

Early Phase 1

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

Active, not recruitingNCT05477823

University of Wisconsin, MadisonProstate Cancer

Start: 2023-03-08End: 2027-08-01Updated: 2026-03-20

Phase 1

PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer

Active, not recruitingNCT05245006

Robert Flavell, MD, PhDMetastatic Castration-resistant Prostate Cancer, Prostate Cancer

Start: 2022-03-18End: 2027-07-31Updated: 2026-03-17

Related Papers

CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment

Journal of Experimental & Clinical Cancer Research2023-03-1135 citations